United States
University of Glasgow - COVID-19 in LMICs Research Group
COVID-19, SARS-CoV-2, igg, antibody, antibodies, vaccine, vaccination, vaccinated, serology, serum, diabetes, ckd, cancer, immune, immunology, impaired, insufficient, insufficient-response, impaired-response, non-responders, risks, QCOVID, clinical-risks, multimorbidity, comorbidity
COVID-19, diagnostics, rapid antigen testing, syndromic surveillance, community, low and middle income country, LMICs, Sensitivity, Specificity, accuracy, global health, Bangladesh, mobile health, symptomatic
calibration, agent-based models, individual-based models, pruning, HPVsim, sequential model-based optimisation
infectious disease modelling, Gaussian Processes, prediction, Machine learning, inverse modelling, Tuberculosis